Stockman, A key observation I had watching the White House Pharma roundtable was that CEO Kim was the only one in the room who asked Trump directly for Federal Money to expand the vaccine production beyond 1,000,000 due by the end of 2020.
Nobody in their right mind would sit in front of the President, especially this President, and ask for money and not deliver as promised. The stakes are high for Kim to be making such a request so he has to deliver on his promise.
There are all kinds of new technologies that it took society and medical science a long time to accept. Case in point: solar panels and electric cars. Carter encouraged solar panels, Reagan crushed the momentum in favor of the oil industry. He even tore Carters solar panels off of the roof of the White House. Here it is 42 years after Carters Presidency and we are finally making inroads with solar panels. Other technology that was slow to adapt: electric cars. The technology has been around for a very long time but the majority of cars being sold today still run on gas.
If Inovio hasn't been able to break the ice on DNA vaccines until now, its likely because of this resistance to change. That will all change with their DNA based vaccine for corona virus. The window of opportunity has arrived based on need. Just like electric cars and solar panels, the time for DNA based vaccines has come.
DNA based vaccines is future science that is on the cusp of exploding. At present, "currently no DNA vaccines have been approved for human use. Research is investigating the approach for viral, bacterial and parasitic diseases in humans, as well as for several cancers." This is why Inovio has not had an approval yet. Government red tape. Thats all going to change with this DNA based vaccine because we no longer have the luxury of waiting for new science to take over.
DNA vaccines are 3rd generation vaccines. Inovio is mentioned here on Wikipedia for their development of DNA vaccines. This is a science that is on the verge of taking hold. The opportunity exists today to move the science forward and Inovio is in a unique position to do just that.
Market Data 
Markets 
AI
